- Trials with a EudraCT protocol (159)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
159 result(s) found for: Acute Kidney Injury.
Displaying page 1 of 8.
EudraCT Number: 2021-002505-10 | Sponsor Protocol Number: NL77754.018.21 | Start Date*: 2021-11-30 | |||||||||||||||||||||
Sponsor Name:Amsterdam University Medical Centre | |||||||||||||||||||||||
Full Title: Rescue Alkaline Phosphatase In Defense against all cause Acute Kidney Injury (RAPID-AKI) | |||||||||||||||||||||||
Medical condition: Acute kidney injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004607-39 | Sponsor Protocol Number: 2013-00460739 | Start Date*: 2014-04-11 |
Sponsor Name:CUB Hopital Erasme | ||
Full Title: Safety of preoperative administration of hemin to reduce the risk of acute kidney injury after on-pump cardiac surgery: a pilot randomised study in double blind. | ||
Medical condition: Acute kidney injury which is associated with on-pump cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004979-39 | Sponsor Protocol Number: 8.1 | Start Date*: 2014-12-19 |
Sponsor Name:VieCuri Medical Center | ||
Full Title: Levosimendan in Acute Kidney Injury Study, a prospective, randomized, monocenter, double blind, placebo-controlled study to investigate the efficacy and safety of Levosimendan in Intensive Care Pat... | ||
Medical condition: Acute Kidney Injury (AKI) in adult ICU patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003259-24 | Sponsor Protocol Number: 0360 | Start Date*: 2015-12-07 | |||||||||||
Sponsor Name:University of Leicester | |||||||||||||
Full Title: The Effect of Sildenafil (REVATIO®) on Post Cardiac Surgery Acute Kidney Injury: A Randomised, Placebo-controlled Phase IIb Clinical Trial: The REVAKI-2 Trial | |||||||||||||
Medical condition: Post cardiac surgery acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000487-28 | Sponsor Protocol Number: PROTECTION | Start Date*: 2018-08-06 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: Intravenous amino acid therapy for kidney protection in cardiac surgery: a multi-centre randomised blinded placebo controlled clinical trial | |||||||||||||
Medical condition: Patients undergoing cardiac surgery at risk for developing acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004938-11 | Sponsor Protocol Number: PI-GR-21-2386 | Start Date*: 2021-12-21 |
Sponsor Name:Hospital Clínico Universitario de Valladolid | ||
Full Title: Prevention of cardiac surgery-associated acute kidney injury through the use of sodium-glucose cotransporter 2 inhibitors | ||
Medical condition: Cardiac surgery-associated acute kidney injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000794-47 | Sponsor Protocol Number: CTIN816A12201 | Start Date*: 2023-01-13 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: A randomized, multi-centric, placebo-controlled, participant and investigator-blinded study to evaluate the safety, tolerability and efficacy of TIN816 in adult patients at risk for acute kidney in... | |||||||||||||
Medical condition: Acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Ongoing) CZ (Ongoing) HU (Ongoing) EE (Ongoing) LT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004854-33 | Sponsor Protocol Number: 03-AnIt-14/UKM14_0066 | Start Date*: 2016-02-05 | ||||||||||||||||
Sponsor Name:University Hospital Muenster | ||||||||||||||||||
Full Title: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH-Trial). | ||||||||||||||||||
Medical condition: Critically ill patients with acute kidney injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023455-28 | Sponsor Protocol Number: 11102010 | Start Date*: 2010-12-15 | |||||||||||
Sponsor Name:Maija Kaukonen | |||||||||||||
Full Title: Dexmedetomidine pharmacokinetics during continuous venovenous hemofiltration and hemodiafiltration in critically ill patients | |||||||||||||
Medical condition: Intensive care patients with acute kidney injury requiring continuous renal replacement therapy with a clinical indication for sedation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003105-25 | Sponsor Protocol Number: MiLe-1 | Start Date*: 2014-08-27 |
Sponsor Name:Sahlgrenska University Hospital / The Queen Silvia Children´s Hospital | ||
Full Title: The prophylactic effect of levosimendan in reducing acute kidney injury postoperatively in pediatric patients undergoing corrective heart surgery | ||
Medical condition: Acute kidney injury postoperatively in connection with surgery for congenital heart disease | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003942-33 | Sponsor Protocol Number: M13-796 | Start Date*: 2013-05-03 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk... | |||||||||||||
Medical condition: Acute Kidney Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002076-41 | Sponsor Protocol Number: 0667 | Start Date*: 2018-08-23 | ||||||||||||||||
Sponsor Name:University of Leicester | ||||||||||||||||||
Full Title: A RANDOMISED CONTROLLED TRIAL OF PRE-SURGERY SODIUM VALPROATE, FOR THE PREVENTION OF ORGAN INJURY IN CARDIAC SURGERY: Val-CARD | ||||||||||||||||||
Medical condition: Reduction of myocardial and kidney injury risk of post cardiac surgery by increasing the expression of genes that promote myocardial mitochondrial homeostasis via effects on chromatin histone deace... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003073-15 | Sponsor Protocol Number: 0504 | Start Date*: 2016-02-12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Research Governance, University of Leicester | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Acute kidney injury post endovascular repair of the abdominal aortic aneurysm. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-003172-13 | Sponsor Protocol Number: MERCURI | Start Date*: 2021-10-14 | |||||||||||
Sponsor Name:Amsterdam UMC | |||||||||||||
Full Title: The renal and metabolic outcomes after sodium-glucose cotransporter 2 inhibitor in cardiac surgery – an open-label phase IV randomized controlled trial | |||||||||||||
Medical condition: Cardiac surgery-associated acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003088-87 | Sponsor Protocol Number: WWU20_0016 | Start Date*: 2021-11-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster | |||||||||||||||||||||||||||||||||
Full Title: Biomarker-guided implementation of angiotensin-II (AT-II) to reduce the occurrence of kidney damage after cardiac surgery | |||||||||||||||||||||||||||||||||
Medical condition: Cardiac surgical patients at high risk for AKI | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004446-29 | Sponsor Protocol Number: LIBERAL-Trial | Start Date*: 2017-10-30 | |||||||||||
Sponsor Name:University Hospital Wuerzburg, Institution under public law, represented by the Medical Director | |||||||||||||
Full Title: Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients | |||||||||||||
Medical condition: Elderly patients (>= 70 years) undergoing intermediate- or high-risk non-cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005710-19 | Sponsor Protocol Number: M13-958 | Start Date*: 2013-10-28 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High ... | |||||||||||||
Medical condition: Acute Kidney Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003113-15 | Sponsor Protocol Number: QRK209 | Start Date*: 2016-08-02 | |||||||||||
Sponsor Name:Quark Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI following Ca... | |||||||||||||
Medical condition: QPI-1002 is being developed for prevention of acute kidney injury (AKI) in patients at risk for AKI following cardiac surgery and for reduction in the incidence and severity of delayed graft functi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005235-22 | Sponsor Protocol Number: ANZIC-RC/RB002 | Start Date*: 2012-01-18 | |||||||||||
Sponsor Name:Monash University | |||||||||||||
Full Title: A randomised, placebo-controlled trial of erythropoietin in ICU patients with traumatic brain injury: Erythropoietin in Traumatic Brain Injury | |||||||||||||
Medical condition: Traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) FR (Ongoing) DE (Ongoing) IE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003000-32 | Sponsor Protocol Number: ACTRN12619001355167 | Start Date*: 2023-06-23 | |||||||||||||||||||||
Sponsor Name:Monash University | |||||||||||||||||||||||
Full Title: 20% Albumin infusion and AKI following cardiac surgery – Randomised Trial | |||||||||||||||||||||||
Medical condition: Acute kidney injury (AKI) is a common complication of cardiac surgery. AKI is defined according to KDIGO criteria in 3 severity stages. KDIGO creatinine-based criteria for diagnosis and staging of... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.